Hangzhou Coco Healthcare Products Co.Ltd. (301009) — Working Capital to Net Assets Ratio
Hangzhou Coco Healthcare Products Co.Ltd. (301009) has a Working Capital to Net Assets ratio of 48.5% as of September 2025. Working capital of CN¥684.27 Million (current assets of CN¥1.38 Billion minus current liabilities of CN¥691.73 Million) is measured against net assets of CN¥1.41 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 301009 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Hangzhou Coco Healthcare Products Co.Ltd. Working Capital to Net Assets (2017–2024)
This chart shows how Hangzhou Coco Healthcare Products Co.Ltd.'s Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 48.5%, reflecting working capital of CN¥684.27 Million against net assets of CN¥1.41 Billion CNY. See Hangzhou Coco Healthcare Products Co.Ltd (301009) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Hangzhou Coco Healthcare Products Co.Ltd.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 45.9% | CN¥647.99 Million | CN¥1.41 Billion | CN¥1.28 Billion | CN¥627.67 Million | ▼ -3.7 pp |
| 2023 | 49.6% | CN¥719.42 Million | CN¥1.45 Billion | CN¥1.20 Billion | CN¥485.30 Million | ▲ +1.9 pp |
| 2022 | 47.8% | CN¥683.99 Million | CN¥1.43 Billion | CN¥1.16 Billion | CN¥474.54 Million | ▲ +2.2 pp |
| 2021 | 45.6% | CN¥687.12 Million | CN¥1.51 Billion | CN¥1.25 Billion | CN¥566.67 Million | ▲ +39.2 pp |
| 2020 | 6.4% | CN¥43.81 Million | CN¥681.55 Million | CN¥849.49 Million | CN¥805.68 Million | ▲ +14.7 pp |
| 2019 | -8.3% | CN¥-37.97 Million | CN¥458.05 Million | CN¥569.97 Million | CN¥607.93 Million | ▼ -26.9 pp |
| 2018 | 18.6% | CN¥99.48 Million | CN¥535.64 Million | CN¥555.54 Million | CN¥456.06 Million | ▲ +2.9 pp |
| 2017 | 15.6% | CN¥73.83 Million | CN¥472.55 Million | CN¥556.45 Million | CN¥482.62 Million | — |